EXOCRINE PANCREAS CARCINOMA
Clinical trials for EXOCRINE PANCREAS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new EXOCRINE PANCREAS CARCINOMA trials appear
Sign up with your email to follow new studies for EXOCRINE PANCREAS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to block cancer growth in RAS-Mutant tumors
Disease control OngoingThis phase II trial is testing whether combining two targeted drugs, palbociclib and binimetinib, can help people with cancers that have RAS mutations. The study includes patients with pancreatic cancer, ovarian cancer, and other solid tumors. Researchers want to see if the drug …
Matched conditions: EXOCRINE PANCREAS CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Cancer treatment gets personal: MATCH trial tests Gene-Guided drugs
Knowledge-focused OngoingThis phase II trial, called MATCH, is testing whether treating cancer based on the genetic makeup of a patient's tumor works better than standard treatments. Over 6,400 adults with advanced solid tumors, lymphomas, or multiple myeloma that have not responded to prior therapy are …
Matched conditions: EXOCRINE PANCREAS CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jul 02, 2026 05:00 UTC